IgG formation to mammalian proteins in hemophilia A patients following treatment with a new recombinant human factor VIII.
Larson
P
P
Zhang
C
C
Gorina
E
E
Getz
E Burmeister
EB
D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis; D006224:Cricetinae; D004342:Drug Hypersensitivity; D005169:Factor VIII / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis*; D051379:Mice; D011506:Proteins / Q000276:immunology; D012189:Retrospective Studies
D000910:Antibodies, Heterophile; D007074:Immunoglobulin G; D011506:Proteins; C078147:F8 protein, human; D005169:Factor VIII